Kemiex Revenue and Competitors
Estimated Revenue & Valuation
- Kemiex's estimated annual revenue is currently $3.9M per year.
- Kemiex's estimated revenue per employee is $116,000
Employee Data
- Kemiex has 34 Employees.
- Kemiex grew their employee count by 10% last year.
Kemiex's People
Name | Title | Email/Phone |
---|
Kemiex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 38 | N/A | N/A | N/A |
#2 | $2.5M | 25 | -11% | N/A | N/A |
#3 | $7.7M | 59 | 28% | N/A | N/A |
#4 | $83.9M | 463 | 33% | N/A | N/A |
#5 | $9M | 69 | -12% | N/A | N/A |
#6 | $4.1M | 35 | 6% | N/A | N/A |
#7 | $32.5M | 204 | 20% | N/A | N/A |
#8 | $4.2M | 36 | -16% | N/A | N/A |
#9 | $8.2M | 63 | 24% | N/A | N/A |
#10 | $3.9M | 34 | 10% | N/A | N/A |
What Is Kemiex?
Swiss-based and independent KEMIEX is a specialized trade and information platform for buyers, traders and sellers of 5'000 active ingredients (APIs), additives, vitamins and excipients in human and animal health and nutrition industries. This service is operated in strategic cooperation with ATRADIUS trade credit insurance and SGS, which provide integrated credit risk insights and insurance, as well as quality related services directly to our members. Our vision is SAFE TRADING. RELIABLE COUNTERPARTIES. WORLDWIDE. www.kemiex.com
keywords:N/AN/A
Total Funding
34
Number of Employees
$3.9M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kemiex News
Kemiex also provided data on vitamin C purchases by the EU in 2021, with the bloc importing 59,800 mt of that product and its derivatives. China...
There has been limited adverse impact, so far, on container freight rates from the COVID-19 imposed restrictions in China. Kemiex said its...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.9M | 34 | -6% | N/A |
#2 | $3.9M | 34 | 6% | N/A |
#3 | $5.7M | 34 | 70% | N/A |
#4 | $4.9M | 34 | 42% | N/A |
#5 | N/A | 34 | 79% | N/A |